HiloProbe
Improving treatment of colorectal cancer
- CEO: Lina Olsson
- First investment year: 2018
- Fund: Partnerinvest North
- Business sector: Life Science

HiloProbe has developed ColoNode®, a highly accurate and rapid test to identify a patient’s need of additional treatment after surgery for colorectal cancer.